TTF1 and breast cancer: The pathology of the thyroid samples disclosed a secondary malignancy of poorly differentiated breast cancer with immunophenotypes CK7+, CK 20-, GATA3+, TTF-1-, P40-, S100-, CDX-2-, Thyroglobulin-, Pax8-, and P63-.